| Cancer Type |
Breast Cancer |
| Grade |
G3 |
| Stage |
NA |
| Gender |
NA |
| Age |
54 |
| Pathology Diagnosis |
IDC. Invasive ductal carcinoma, grade 3 poorly differentiated, DCIS low nuclear grade. PanCK+, CAM5.2-,Vim+, ,hCD45-, Ecad+. Clinical metastasis, brain, lung and Bone. |
| Biopsy Site |
Skin metastasis |
| Treatment History |
16-0017348 AC-T, 3-2014- 9-2015, Xgeva 9-15 - 6-2016, Olaparib 9-2015-4-2016, add carboplatin 1-2016-4-2016, 4-2016 PD1 inhibitor trial, Xeloda 6-2016, progressive disease |
| Pathology QC |
Invasive ductal carcinoma (P7). |
| Special Features |
IHC (P5): HER2(0.5+), ER(-), PR(-); primary-met pair with BR9479; Slow growth rate, slight ulceration |
| Mouse Strain |
NOD.SCID |
| TMA |
NA |
| Viral Status in PDX |
NA |
| Available In |
CB_CN |
| RNA Seq |
P3 |
| Exome Seq |
P3 |
